Auzen Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.40 M
as on 30-06-2024
- Paid Up Capital ₹ 4.39 M
as on 30-06-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 10419.58%
(FY 2022)
- Profit 21750.34%
(FY 2022)
- Ebitda -27.11%
(FY 2022)
- Net Worth 10.92%
(FY 2022)
- Total Assets 18.50%
(FY 2022)
About Auzen Life Sciences
The Corporate was formerly known as Capable Commodities Private Limited. The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.40 M and a paid-up capital of Rs 4.39 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Gupta and Ajay Gupta serve as directors at the Company.
- CIN/LLPIN
U74110WB2012PTC172414
- Company No.
172414
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Auzen Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Gupta  | Director | 29-Jan-2018 | Current |
| Ajay Gupta | Director | 29-Jan-2018 | Current |
Financial Performance and Corporate Structure Insights of Auzen Life Sciences.
Auzen Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10419.58% increase. The company also saw a substantial improvement in profitability, with a 21750.34% increase in profit. The company's net worth Soared by an impressive increase of 10.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Auzen Life Sciences?
In 2021, Auzen Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gelcon Healthcare Private LimitedActive 4 years 9 monthsSantosh Gupta and Ajay Gupta are mutual person
- Ganeshvani Retails Private LimitedActive 12 years 11 months
Santosh Gupta and Ajay Gupta are mutual person
- Goldensons Tie Up Private LimitedActive 12 years 9 months
Santosh Gupta and Ajay Gupta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Auzen Life Sciences?
Unlock and access historical data on people associated with Auzen Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auzen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auzen Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
